EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 9th, 2020 • UroGen Pharma Ltd. • Pharmaceutical preparations • New York
This Executive Employment Agreement (the “Agreement”), is hereby made this 3rd day of September, 2020, between UroGen Pharma, Inc., a wholly owned subsidiary (the “Subsidiary”) of UroGen Pharma, Ltd. (the “Parent”, and the Subsidiary and the Parent together, the “Company”), and Molly Henderson (the “Executive”) (collectively, the “Parties”).
September 8, 2020 Peter Pfreundschuh Dear Peter:Separation Agreement • September 9th, 2020 • UroGen Pharma Ltd. • Pharmaceutical preparations
This letter sets forth the substance of the separation agreement (the “Agreement”) that UroGen Pharma, Inc. (the “Company”) is offering to you to aid in your employment transition, and in accordance with the Executive Employment Agreement between the Company and you, dated July 31, 2018 (the “Employment Agreement”).
